Citigroup Inc. : The technical rebound to run out of steam
Published on 03/06/2019
at 04:50 pm GMT
| Entry price | Target | Stop-loss | Potential |
|---|
|
US$62.94 |
US$56.1 |
US$66.3 |
+10.87% |
|---|
The end of the technical rebound appears close for stocks in Citigroup Inc. following the recovery of the past few days.
Strengths● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● Revenue estimates are regularly revised downwards for the current and coming years.
© MarketScreener.com -
2019
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener UK. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
